News | Image Guided Radiation Therapy (IGRT) | September 16, 2019

Varian Unveils Ethos Solution for Adaptive Radiation Therapy

Artificial intelligence-powered system designed to deliver adaptive therapy treatment in a typical 15-minute timeslot

Varian Unveils Ethos Solution for Adaptive Radiation Therapy

September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Adaptive therapy provides the ability to alter the treatment plan based on tumor and anatomical changes. The goal is to better target the tumor, reduce dose to healthy tissue and potentially improve overall outcomes.

The streamlined workflow of Ethos therapy is enabled by its AI-driven planning and contouring capabilities. The physician defines their clinical intent from predefined templates and the initial treatment plan is generated based on the physician's intent. The treatment plan is adapted in response to the variability of the tumor's shape and cellular characteristics, along with fluctuations in the tumor's position due to changes in nearby organs. The ability of Ethos to deliver on-couch adaptive treatment puts the patient at the center of care.

Ethos therapy offers the use of multimodality images — including magnetic resonance (MR), positron emission tomography (PET) and computed tomography (CT) — and daily iterative cone beam computed tomography (CBCT) images at the console.  By providing an up-to-date view of the patient's anatomy, Ethos therapy provides clinicians the confidence to make more informed adaptive treatment decisions. The solution is built on Varian's latest treatment delivery technology, and provides fast imaging and treatment delivery without compromising quality.

"Ethos therapy will enable our physicians to better visualize the changes in a patient's anatomy and quickly adapt the therapy accordingly to help provide better treatments to patients," said Poul Geertsen, M.D., Ph.D., head of radiotherapy, Department of Oncology at Herlev and Gentofte Hospital, Copenhagen, Denmark. "We have already delivered the first Ethos therapy treatment, and our clinical staff was impressed by the capabilities and the ability to deliver this advanced treatment in a typical timeslot."

To advance the worldwide adoption of intelligent adaptive therapy, Varian formed the Adaptive Intelligence Consortium in April 2019. Participants include clinicians and scientists from leading cancer clinics across the globe. The consortium will lead clinical trials to develop evidence-based clinical protocols for Ethos therapy.

Ethos therapy has received CE mark and is currently U.S. Food and Drug Administration (FDA) 510(k) pending and not for sale in all markets.

Watch the 2019 ASTRO VIDEO: Artificial Intelligence Driven Adaptive Radiotherapy System Begins Treating Patients — Interview with David Sjostrom, Ph.D., deputy chief physicist, Herlev Hospital

For more information: www.varian.com

Related Content

Study conducted by medical AI startup Lunit and Massachusetts General Hospital, published in JAMA Network Open - When used as a second reader, the AI algorithm may help detect lung cancer
News | Artificial Intelligence | November 26, 2020
November 26, 2020 — A recent study published in ...
Philips Smart diagnostic systems empower patients and staff with more definitive diagnostic and interventional radiology studies, optimized workflows, enhanced efficiency and operational excellence
News | Artificial Intelligence | November 25, 2020
November 25, 2020 — Philips announced its participation in the RSNA...
 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th...
New multimodality virtual imaging command center enables real-time, remote collaboration to broaden expertise between technologists, radiologists and imaging operations teams across multiple sites via private, secure telepresence capabilities
News | Information Technology | November 24, 2020
November 24, 2020 — Philips announced commercial launch of the industry’s first vendor-neutral, multimodality, radiol
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for nearly two decades and a preeminent provider of zero-footprint, cloud-based imaging SDKs, today announced that it will be showcasing the continued expansion of its artificial intelligence product portfolio together with Fovia’s advanced imaging solutions at the first Virtual Radiology Society of North America (RSNA) Conference, November 29 - December 5.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in...